The next Ozempic: A 4-in-1 breakthrough for lasting weight loss

Scientists are racing to improve weight loss treatments beyond drugs like Ozempic and Wegovy, which are effective but plagued by nausea, bone loss, and weight regain. Tufts University chemists have created a new multi-target compound that goes beyond the usual GLP-1, GIP, and glucagon approaches by adding a fourth hormone, PYY. This “quadruple-action” design aims to deliver weight loss results on par with bariatric surgery—up to 30%—without invasive procedures, and could change the future of obesity treatment.

Health Sep 2, 2025 0 49 Add to Reading List

The next Ozempic: A 4-in-1 breakthrough for lasting weight loss

WHY THE HEN DOES NOT HAVE TEETH STORY BOOK

It’s an amazing story, composed out of imagination and rich with lessons. You’ll learn how to be morally upright, avoid immoral things, and understand how words can make or destroy peace and harmony.

Click the image to get your copy!

WHY THE HEN DOES NOT HAVE TEETH STORY BOOK

Click the image to get your copy!

WHY THE HEN DOES NOT HAVE TEETH STORY BOOK

Click the image to get your copy!

Scientists are racing to improve weight loss treatments beyond drugs like Ozempic and Wegovy, which are effective but plagued by nausea, bone loss, and weight regain. Tufts University chemists have created a new multi-target compound that goes beyond the usual GLP-1, GIP, and glucagon approaches by adding a fourth hormone, PYY. This “quadruple-action” design aims to deliver weight loss results on par with bariatric surgery—up to 30%—without invasive procedures, and could change the future of obesity treatment.

Read Original